Trademarkia Logo

Canada

C$
Trademark Search in Canada
SEGMENTED SQUARE DESIGN

View On IC.GC.CA

SEGMENTED SQUARE DESIGN
REGISTERED

on 3 Nov 2020

Last Applicant/ Owned by

TETRAPHASE PHARMACEUTICALS INC.

480 Arsenal Street Watertown, MA 02472

US

Serial Number

1903223 filed on 7th Jun 2018

Registration Number

TMA1086925 registered on 3rd Nov 2020

Registration expiry Date

3rd Nov 2030

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

CA

M4T1X3

SEGMENTED SQUARE DESIGN

Trademark usage description

pharmaceutical preparations, namely, antibiotics.

Vienna Information

26 . 4 . 1

SquaresCarrés

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

Classification Information

Class [005]
Pharmaceutical preparations, namely, antibiotics.

Classification kind code

11

Mark Details

Serial Number

1903223

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 55
on 3rd Nov 2020		Registered
Submitted for opposition 190
on 23rd Sept 2020		Registration Pending
Submitted for opposition 191
on 23rd Sept 2020		Registration Fee Notice Sent
Submitted for opposition 42
on 13th May 2020		Advertised
Submitted for opposition 26
on 15th Apr 2020		Approved
Submitted for opposition 27
on 15th Apr 2020		Approval Notice Sent
Submitted for opposition 22
on 7th Apr 2020		Search Recorded
Submitted for opposition 31
on 11th Jun 2018		Formalized
Submitted for opposition 1
on 8th Jun 2018		Created
Submitted for opposition 30
on 7th Jun 2018		Filed